Synaptic vesicle chips to assay botulinum neurotoxins
- 25 October 2005
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 391 (3), 659-666
- https://doi.org/10.1042/bj20050855
Abstract
BoNTs (botulinum neurotoxins), considered to be the most toxic of all biological substances, inhibit neurotransmission through proteolytic cleavage of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins [VAMP (vesicle-associated membrane protein, or synaptobrevin), SNAP-25 (25 kDa synaptosome-associated protein) or syntaxin]. Expansion in the use of BoNTs as therapeutic and cosmetic agents, and the potential threat they constitute as biological weapons, underlines the need for rapid and sensitive in vitro assays. Here, we present new automatized bioassays to detect VAMP cleavage by BoNT/B and F. Western blotting and SPR (surface plasmon resonance) methods revealed that BoNT/B and F totally cleave their substrate on immunoisolated SVs (synaptic vesicles). Real-time monitoring of the immunocapture of native SVs from crude lysates on SPR sensor chips enabled the detection of picogram amounts of different SV proteins. Pre-incubation of a membrane fraction containing SVs with BoNT specifically inhibited capture by anti-VAMP antibodies, and amounts as low as 0.1 pg of BoNT/B were detected. This automated SPR assay is approx. 200 times more sensitive, and 25 times more rapid, than the in vivo BoNT/B test currently used. Moreover, the method can be performed using a few thousand cultured neurons and constitutes a new screening assay for inhibitors. Our data indicate that native VAMP is an optimal substrate for in vitro BoNT assays that can be monitored by SPR.This publication has 37 references indexed in Scilit:
- Botulinum toxins in neurological diseaseMuscle & Nerve, 2004
- Insertion of the Membrane-proximal Region of the Neuronal SNARE Coiled Coil into the MembraneOnline Journal of Public Health Informatics, 2003
- Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type AOnline Journal of Public Health Informatics, 2003
- Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusionNature, 2002
- Endocytosis of Clostridium botulinum Type B Neurotoxin into Rat Brain Synaptosomes.The Journal of Veterinary Medical Science, 2000
- The t-SNAREs syntaxin 1 and SNAP-25 are present on organelles that participate in synaptic vesicle recycling.The Journal of cell biology, 1995
- Peptide Substrate Specificity and Properties of the zinc‐endopeptidase Activity of Botulinum Type B NeurotoxinJBIC Journal of Biological Inorganic Chemistry, 1994
- Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevinNature, 1992
- Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells.The Journal of cell biology, 1986
- Clostridium botulinum toxinsPharmacology & Therapeutics, 1982